10月30日,微创医疗(00853)股价盘中大跌5.04%,报6.41港元。分析认为,这与该公司刚公布的附属心脉医疗科技(688016)前三季度业绩表现不佳有关。
数据显示,心脉医疗科技2024年前三季度实现营收9.7亿元人民币,同比仅增长9.13%,低于市场预期;归母净利润5.53亿元,虽同比增长42.46%,但增速有所放缓。作为微创医疗重要附属公司,心脉医疗科技业绩表现不理想,令市场对微创医疗整体前景的信心受到冲击,从而引发股价大幅下跌。
值得注意的是,微创医疗旗下其他产品线表现如何,对其股价影响亦不可小视。市场正在密切关注微创医疗2024年前三季度整体业绩情况,以便更全面评估公司基本面。分析指出,随着后续年报等信息披露,公司股价走势或将趋稳。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.